Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;25(6):551-555.
doi: 10.1097/MNH.0000000000000281.

Implementing an antimicrobial stewardship program in out-patient dialysis units

Affiliations
Review

Implementing an antimicrobial stewardship program in out-patient dialysis units

Cheston B Cunha et al. Curr Opin Nephrol Hypertens. 2016 Nov.

Abstract

Purpose of review: Rates of multidrug-resistant organisms (MDRO), including methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and multidrug-resistant gram-negative bacteria, continue to rise among the population of chronic hemodialysis. Antimicrobial exposure is the main risk factor for MDRO emergence and dissemination. Up to 30% of antimicrobial doses administered in out-patient dialysis units may not be indicated. Antimicrobial stewardship programs (ASP) improve antimicrobial prescribing patterns. The purpose of this review is to highlight the key elements and interventions of ASP.

Recent findings: The Infectious Disease Society of America and the Society of Healthcare Epidemiology of America have provided evidence-based guidelines for the development and implementation of an ASP. Many of their recommendations can be adapted to the out-patient dialysis setting.

Summary: Developing and implementing an ASP by following key elements and interventions in the out-patient dialysis setting can lead to reduced mortality, adverse events, costs, and improvement in antimicrobial susceptibility rates.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: none

Similar articles

Cited by

References

    1. Karanika S, Zervou FN, Zacharioudakis IM, Paudel S, Miylonakis E. Risk factors for methicillin-resistant Staphylococcus aureus colonization in dialysis patients: a meta-analysis. J Hosp infect. 2015;91:257–63. - PubMed
    1. Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E. Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients. J Am Soc Nephrol. 2014;25:2131–41. A meta-analysis of MRSA outcomes in chronic hemodialysis patients. - PMC - PubMed
    1. Zacharioudakis IM, Zervou FN, Ziakas PD, Rice LB, Mylonakis E. Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significiance. Am J Kidney Dis. 2015;65:88–97. - PubMed
    1. Pop-Vicas A, Strom T, D'Agata EMC. Multidrug-resistant gram-negative bacilli among chronic hemodialysis patients. Clin J Amer Soc Nephrol. 2008;3:752–8. - PMC - PubMed
    1. Snyder GM, Patel PR, Kallen AJ, Strom JA, Tucker JK, D'Agata EMC. Antimicrobial use in out-patient dialysis units. Infect Control Hosp Epidemiol. 2013;34:349–57. - PubMed

MeSH terms

Substances